Elke de Jong
0000-0003-3872-5704
13 papers found
Refreshing results…
National consensus on biologic dose reduction in psoriasis: a modified eDelphi procedure
Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy – a mixed-method pilot study
Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry
Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic
Treatment goals and preferences of pediatric psoriasis patients, young adults, and parents
Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
Two-year Follow-up of a Dose Reduction Strategy Trial of Biologics Adalimumab, Etanercept, and Ustekinumab in Psoriasis Patients in Daily Practice
Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups
The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature
Missing publications? Search for publications with a matching author name.